tranScrip (transcrip)
Is this your company? Claim this profile
Analytical & Bioanalytical Services
Contract Research Organization
Regulatory, Tech Transfer & Support Services
Company Overview
About
tranScrip (transcrip) is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Solid Dose Manufacturing, Oral Liquids, Topicals
Therapeutic Areas
Rare Disease
Metabolic
Quick Facts
HQ:United Kingdom
Founded:2005
Employees:1,442
Capabilities & Services
Core Capabilities
- Biologics Drug Substance
- Biologics Drug Product
- Biologics Manufacturing
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Prefilled Syringe
Sterile Injectable
Production Scales
Phase III Clinical Trials
Commercial Scale
Clinical
Markets Served
North America
Europe
Regulatory Approvals
Drug Approval 1AUDTW
EMA · #APR-T38C2G7X · 2021-01-01
Drug Approval VT1T4C
FDA · #APR-IPDDXWCV · 2020-05-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-HFPW3E2X
Issued: 2020-08-20
Expires: 2025-02-10
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-88MK9RAJ
Issued: 2020-08-22
Expires: 2025-03-15
Health Canada GMP
Health Canada
Cert #: CERT-WXH4JO1G
Issued: 2020-03-11
Expires: 2025-12-19
Loading CDMO intelligence...
Key facts about tranScrip (transcrip)
- tranScrip (transcrip) is headquartered in the United Kingdom.
- tranScrip (transcrip) was founded in 2005.
- tranScrip (transcrip) has 1,442 employees.
- tranScrip (transcrip)'s capabilities include Biologics Drug Substance, Biologics Drug Product and Biologics Manufacturing.
Find CDMOs like tranScrip (transcrip)
Directory pages this company appears in, each with the full list of matching manufacturers.